InsideArbitrage Event Driven Monitor – January 2, 2023
Quick updates on the event-driven strategies we follow on InsideArbitrage. Merger Arbitrage Apollo Endosurgery (APEN) and Boston Scientific (BSX) stated in their preliminary proxy statement that they filed notification and report forms under the HSR Act with the DOJ and the FTC on December 20, 2022. F-star Therapeutics (FSTX) and invoX Pharma extended the tender offer to January 17, 2023, to give CFIUS more time. The End Date has also been extended to January 31, 2023. Canada’s antitrust regulator plans to appeal a decision by a Canadian court that allowed a proposed merger between Rogers Communications (RCI) and Shaw Communications (SJR) to proceed. The Competition Bureau has filed a notice to appeal the decision with a Canadian appellate court. The companies reported that they remain committed to pro-competitive transactions. Farmers National Banc Corp. (FMNB) completed the acquisition of Emclaire Financial (EMCF) According to Reuters, a judge has set January 3, 2023, for the first pre-trial hearing in the Biden administration’s case against Microsoft (MSFT) over its bid to take over Activision Blizzard (ATVI). Brookline Bancorp (BRKL) completed the acquisition of PCSB Financial Corporation (PCSB). Horizon Therapeutics Public Limited Company (HZNP) and Amgen (AMGN), each filed a notification and report form with respect to the transaction with the DOJ and the FTC under the HSR Act on December 29, 2022....
Only plus or premium subscribers can access this post. Subscribe today.
